Pediatric Therapeutics and Pharmacology

Pediatric Therapeutics and Pharmacology

386 - Ultra-low dose ketamine is safe and effective at reducing pain intensity and total opioid requirement in pediatric patients

387 - Physiologically Based Pharmacokinetic Modeling of Intravenous Anakinra Exposure in Children

388 - Using Reverse Image Search and Artificial Intelligence Technology to Identify Prescription Pills

389 - Identification of priority medications for characterizing developmental changes in drug disposition after extremely preterm birth

390 - Off-Label but On the Rise: National Trends of Clonidine Use in U.S. NICUs, 2008–2022

391 - Furosemide pharmacokinetics in infants with established bronchopulmonary dysplasia using whole blood microsampling

392 - Variation in dexamethasone prescribing practices for pediatric asthma exacerbations in acute care settings

393 - SAFE-KIDS: Study of Accuracy and Frequency of Errors in Kids’ Dosing in Acute Care Settings

394 - Application of Pharmacogenomic Testing in Pediatric Kidney Transplant Patients

395 - Impact of Pharmacist-Driven Vancomycin Dosing Utilizing Area Under the Curve (AUC) Software in a Neonatal Intensive Care Unit (NICU)

396 - Antibiotic-induced dilation of the ductus arteriosus: mechanisms and implications for ductus closure and postnatal reopening

397 - Exposure to opioids and benzodiazepines in preterm infants with and without major operative procedures

398 - Development of an Immortalized Ductus Arteriosus (DA) Smooth Muscle Cell (SMC) Platform for High Throughput Drug Screening to Identify Novel Therapeutics for PDA